Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks
Zoetis Inc. (NYSE:ZTS) offers a range of drugs and healthcare products for companion animals and livestock worldwide.
Zoetis Inc. (ZTS)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Heathbridge Capital Management Robert Richards | 60,050 | $8,786,516 | -2% | 3.37% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 16,440 | $2,405,501 | +2% | 0.05% |
| 3. | Beech Hill Partners Paul Cantor, Joseph Weiss, And Will Wurm | 1,496 | $218,895 | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.48 | 2,100 | $347,508.00 | 7,590 | 2021-02-19 | Filing | |
| $164.89 | 2,900 | $478,181.00 | 5,490 | 2021-02-19 | Filing | |
| $163.80 | 2,590 | $424,242.00 | 2,590 | 2021-02-19 | Filing | |
| $74.56 | 10 | $745.60 | 17 | 2018-01-11 | Filing | |
| $50.31 | 7 | $352.17 | 7 | 2016-10-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $170.00 | 652 | $110,840.00 | 15,129 | 2025-06-03 | Filing | |
| $170.00 | 326 | $55,420.00 | 15,781 | 2025-03-10 | Filing | |
| $166.14 | 1,210 | $201,029.40 | 11,245 | 2025-03-11 | Filing | |
| $156.68 | 382 | $59,852.26 | 94,194 | 2025-02-19 | Filing | |
| $171.18 | 326 | $55,804.68 | 16,107 | 2025-02-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,436,888 | $356,565,452 | 0.36% | |
| 2. | 1,649,946 | $236,041,286 | 2.32% | |
| 3. | 1,274,153 | $186,434,067 | 0.56% | |
| 4. | 696,187 | $101,866,082 | 0.14% | |
| 5. | 358,896 | $52,513,722 | 0.69% |
News See All
13 Most Profitable Dividend Stocks to Buy Right Now
In a period marked by market volatility, ongoing policy and geopolitical uncertainty, many investors have been shifting toward fixed-income assets and away...
Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025
Zoetis Inc. (NYSE:ZTS), a global leader in animal health, reported solid second-quarter 2025 results with revenue rising 4% year-over-year to $2.5 billion and net income up 15% to $718 million.
12 Best Healthcare Stocks to Buy and Hold for 5 Years
Most Americans have endured the annoyance of having their health insurance denied, frequently with no resolution even after contacting carriers via phone and email. This can be changed by Dr.
EMA Gives Positive Opinion on Zoetis Inc. (ZTS)’ Cat Arthritis Therapy, Portela
Zoetis Inc. (NYSE:ZTS) continues to strengthen its position as a global leader in animal health, with steady growth and expanding innovation.
10 Best Pharma Stocks to Buy According to Billionaires
Recently, President Trump wrote letters to 17 major pharmaceutical firms outlining the actions they should take to bring the prices of prescription pharmaceuticals in the United States down to "most favored...
Zoetis (ZTS) Receives Positive Opinion from CVMP for Portela®
Zoetis Inc. (NYSE:ZTS) is one of the best drug stocks to buy right now. Zoetis Inc.
12 Best Drug Stocks to Buy Right Now
Dr. Marty stated that these ads are, by regulation, supposed to create a fair balance of information.
Zoetis Inc. (ZTS) Secures a New Five-Year $1.25 Billion Senior Unsecured Revolving Credit Facility
Zoetis Inc. (NYSE:ZTS) strengthened its financial flexibility on August 27, 2025, by securing a new five-year, $1.25 billion senior unsecured revolving credit facility.
11 Best Roth IRA Stocks to Invest in Now
One of the most powerful tools available for long-term wealth creation is a Roth IRA.